Is Summit Therapeutics a Millionaire Maker?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (NASDAQ: SMMT). The drugmaker’s shares are up by nearly 540%, thanks to excellent clinical progress for its leading pipeline candidate, ivonescimab, a cancer treatment in de
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-724230669-d36989e94ccb423fa2ba66e64f9be3f1.jpg "Home Equity Loan vs. Personal Loan: What’s the Difference?")
:max_bytes(150000):strip_icc():format(jpeg)/SupremeCourtOutside-4086612ddc684eb28a41d4a4f6dccc8a.jpeg "Top 10 U.S. Economic Indicators")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1886368138-bb1e2bb64b914da789507a505339915f.jpg "Why Is Deflation Bad for the Economy?")
